Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laboratorios Farmaceuticos Rovi's inventories, raw materials & components for the quarter that ended in Jun. 2026 was MXN2,027 Mil.
Laboratorios Farmaceuticos Rovi's quarterly raw materials
declined
from Dec. 2025 (MXN2,167 Mil) to Mar. 2026 (MXN0 Mil) but then
increased
from Mar. 2026 (MXN0 Mil) to Jun. 2026 (MXN2,027 Mil).
Laboratorios Farmaceuticos Rovi's annual raw materials
declined
from Dec. 2023 (MXN3,135 Mil) to Dec. 2024 (MXN2,319 Mil) and
declined
from Dec. 2024 (MXN2,319 Mil) to Dec. 2025 (MXN2,167 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of MXN2,027 Mil mean?
Laboratorios Farmaceuticos Rovi (MEX:ROVIN) has a Inventories, Raw Materials & Components of MXN2,027 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Laboratorios Farmaceuticos Rovi and its competitors.
Is Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components too high?
Laboratorios Farmaceuticos Rovi's current Inventories, Raw Materials & Components is MXN2,027 Mil. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components of MXN2,027 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. Laboratorios Farmaceuticos Rovi's current Inventories, Raw Materials & Components is MXN2,027 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Laboratorios Farmaceuticos Rovi (MEX:ROVIN) has a current Inventories, Raw Materials & Components of MXN2,027 Mil. The stock's GF Value™ is MXN1,103.32, compared to a current price of MXN1,168.82 — trading 5.9% above its estimated fair value. The current Inventories, Raw Materials & Components is MXN2,027 Mil. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (MEX:ROVIN), the current Inventories, Raw Materials & Components is MXN2,027 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorios Farmaceuticos Rovi (MEX:ROVIN) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued.
The current stock price of MXN1,168.82 is trading 5.9% above its estimated GF Value™ of MXN1,103.32.
Key valuation signals for MEX:ROVIN:
Inventories, Raw Materials & Components: MXN2,027 Mil
GF Value™: MXN1,103.32 vs. price of MXN1,168.82 (5.9% above fair value)
No single metric tells the full story. See the MEX:ROVIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
81GF Score
Get the complete analysis for MEX:ROVIN
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ROVIN has been successfully added to your 
